VAXX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own VAXX shares is 3, representing 0.02% of the company's common stock.

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, in the last quarter, reduced its stake in VAXX by -100% restricting it's holding to 0 shares of worth nearly -. HOLLENCREST CAPITAL MANAGEMENT also lessened -100% of the VAXX shares from its portfolio, reducing its holding to 0 shares of worth -. ADVISORY SERVICES NETWORK, LLC also shunned VAXX shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, VANGUARD GROUP INC increased its stake in VAXX by 0.87% in the last quarter. The institutional holder raised its holding to 2.41 million shares having worth more than $1.73M. GEODE CAPITAL MANAGEMENT, LLC also added 4.34% more shares of VAXX to its portfolio, raising its holding to 878.54 thousand shares of worth $630.43K. RENAISSANCE TECHNOLOGIES LLC also increased its VAXX shares holding by 100% which brought its holding to 35.1 thousand shares worth $25.00K.

The insider with the most stakes in VAXX is Reese Lou , Executive Chairman at the company. Additionally, VAXX stock is highly held by See Remarks Hu Mei Mei and UNITED BIOMEDICAL INC among others.

Company executives, directors, and other insiders own 50.71% percent of Vaxxinity, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which VAXX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include PRIME MOVERS LAB FUND I LP, SLOSS DAKIN, and DIAMANDIS PETER.

There have been 0 transaction(s) during the past 6-months in which Vaxxinity, Inc. insiders have bought stock, totalling 0 shares

Around 0 Vaxxinity, Inc. shares are held by insiders, which represents about 50.71% of VAXX stock.

VAXX Executive Chairman, Reese Lou holds the largest portfolio of the company's shares. VAXX shares owned by Reese total nearly 51.74 million.

LINCOLN NATIONAL CORP is the largest institutional owner in VAXX which holds 41.07 thousand shares worth $29.47K or 0.03% of the total VAXX shares outstanding followed by KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC with ownership of 0 shares representing 0% of the VAXX ownership. HOLLENCREST CAPITAL MANAGEMENT is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the VAXX is concerned, it is a stock which is not optionable.

Number of VAXX shares short is 4.22M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 112.91M shares of VAXX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, VAXX has 55.62M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for VAXX is 13.97.